These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35071746)
21. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice. Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803 [TBL] [Abstract][Full Text] [Related]
22. CD46 represents a target for adenoviral gene therapy of malignant glioma. Ulasov IV; Tyler MA; Zheng S; Han Y; Lesniak MS Hum Gene Ther; 2006 May; 17(5):556-64. PubMed ID: 16716112 [TBL] [Abstract][Full Text] [Related]
23. GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory. Rivera-Molina Y; Jiang H; Fueyo J; Nguyen T; Shin DH; Youssef G; Fan X; Gumin J; Alonso MM; Phadnis S; Lang FF; Gomez-Manzano C Neurooncol Adv; 2019; 1(1):vdz009. PubMed ID: 31608328 [TBL] [Abstract][Full Text] [Related]
24. Characterization of infectivity of knob-modified adenoviral vectors in glioma. Paul CP; Everts M; Glasgow JN; Dent P; Fisher PB; Ulasov IV; Lesniak MS; Stoff-Khalili MA; Roth JC; Preuss MA; Dirven CM; Lamfers ML; Siegal GP; Zhu ZB; Curiel DT Cancer Biol Ther; 2008 May; 7(5):786-93. PubMed ID: 18756624 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses. Yotnda P; Zompeta C; Heslop HE; Andreeff M; Brenner MK; Marini F Hum Gene Ther; 2004 Dec; 15(12):1229-42. PubMed ID: 15684699 [TBL] [Abstract][Full Text] [Related]
26. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds. Stoff A; Rivera AA; Banerjee NS; Mathis JM; Espinosa-de-los-Monteros A; Le LP; De la Torre JI; Vasconez LO; Broker TR; Richter DF; Stoff-Khalili MA; Curiel DT Wound Repair Regen; 2006; 14(5):608-17. PubMed ID: 17014674 [TBL] [Abstract][Full Text] [Related]
27. A tropism-transformed Oncolytic Adenovirus with Dual Capsid Modifications for enhanced Glioblastoma Therapy. Wang L; Liu W; Li Z; Wang X; Feng X; Wang Z; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X J Cancer; 2020; 11(19):5713-5726. PubMed ID: 32913465 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanoma. Hoffmann D; Bayer W; Heim A; Potthoff A; Nettelbeck DM; Wildner O J Invest Dermatol; 2008 Apr; 128(4):988-98. PubMed ID: 17960177 [TBL] [Abstract][Full Text] [Related]
29. Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment. Davydova J; Le LP; Gavrikova T; Wang M; Krasnykh V; Yamamoto M Cancer Res; 2004 Jun; 64(12):4319-27. PubMed ID: 15205347 [TBL] [Abstract][Full Text] [Related]
30. Adenovirus type 5 substituted with type 11 or 35 fiber structure increases its infectivity to human cells enabling dual gene transfer in CD46-dependent and -independent manners. Yu L; Shimozato O; Li Q; Kawamura K; Ma G; Namba M; Ogawa T; Kaiho I; Tagawa M Anticancer Res; 2007; 27(4B):2311-6. PubMed ID: 17695519 [TBL] [Abstract][Full Text] [Related]
31. Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations. Ene CI; Fueyo J; Lang FF Neurosurg Focus; 2021 Feb; 50(2):E6. PubMed ID: 33524949 [TBL] [Abstract][Full Text] [Related]
32. Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd). Rocconi RP; Zhu ZB; Stoff-Khalili M; Rivera AA; Lu B; Wang M; Alvarez RD; Curiel DT; Makhija SK Gynecol Oncol; 2007 Apr; 105(1):113-21. PubMed ID: 17173958 [TBL] [Abstract][Full Text] [Related]
33. Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses. Schmitz M; Graf C; Gut T; Sirena D; Peter I; Dummer R; Greber UF; Hemmi S Gene Ther; 2006 Jun; 13(11):893-905. PubMed ID: 16482201 [TBL] [Abstract][Full Text] [Related]
34. Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses. Reddy PS; Ganesh S; Yu DC Clin Cancer Res; 2006 May; 12(9):2869-78. PubMed ID: 16675583 [TBL] [Abstract][Full Text] [Related]
35. Selective effects of a fiber chimeric conditionally replicative adenovirus armed with hep27 gene on renal cancer cell. Fang L; Cheng Q; Liu W; Zhang J; Ge Y; Zhang Q; Li L; Liu J; Zheng J Cancer Biol Ther; 2016 Jun; 17(6):664-73. PubMed ID: 27195521 [TBL] [Abstract][Full Text] [Related]
36. Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system. Stoff-Khalili MA; Stoff A; Rivera AA; Mathis JM; Everts M; Wang M; Kawakami Y; Waehler R; Mathews QL; Yamamoto M; Rocconi RP; Siegal GP; Richter DF; Dall P; Zhu ZB; Curiel DT Cancer Biol Ther; 2005 Nov; 4(11):1203-10. PubMed ID: 16177567 [TBL] [Abstract][Full Text] [Related]
37. Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection. González-Morales A; Zabaleta A; Guruceaga E; Alonso MM; García-Moure M; Fernández-Irigoyen J; Santamaría E Oncotarget; 2018 Jul; 9(57):31045-31065. PubMed ID: 30123426 [TBL] [Abstract][Full Text] [Related]
38. Oncolytic adenovirus Delta-24-RGD induces a widespread glioma proteotype remodeling during autophagy. González-Morales A; Zabaleta A; García-Moure M; Alonso MM; Fernández-Irigoyen J; Santamaría E J Proteomics; 2019 Mar; 194():168-178. PubMed ID: 30503830 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma. Hoffmann D; Heim A; Nettelbeck DM; Steinstraesser L; Wildner O Hum Gene Ther; 2007 Jan; 18(1):51-62. PubMed ID: 17184155 [TBL] [Abstract][Full Text] [Related]
40. 5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells. He X; Liu J; Yang C; Su C; Zhou C; Zhang Q; Li L; Wu H; Liu X; Wu M; Qian Q Hum Gene Ther; 2011 Mar; 22(3):283-92. PubMed ID: 20846024 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]